HELENE MUHIRWA: Open Payments
NPI 1821530833 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 35 payments from 7 companies in 2025. Trend: 2023 $826 · 2024 $799 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $242 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $173 |
| Janssen Pharmaceuticals, Inc | 2 | $159 |
| Axsome Therapeutics, Inc. | 3 | $145 |
| Indivior Inc. | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, INVEGA SUSTENNA, Auvelity, SUBLOCADE, ABILIFY MAINTENA, COBENFY, SPRAVATO.
Industry payments across OH — which companies pay providers there.
